Retractable Technologies, Inc. (NYSE MKT: RVP) announced today the
launch of a new innovative product, the VanishPoint® Blood
Collection Set (BCS).
The VanishPoint® BCS is a novel safety blood collection
device for diagnostic purposes that provides the ease of a shorter blood
collection needle with preattached tubing. The unique design has
integrated finger grips allowing for handling ease without the need for
wings, which can interfere with disposal. The automated needle
retraction is activated by depressing a retraction trigger located near
the finger grip area, allowing for easy one-handed activation, without
changes in hand position, while reducing the risk of inadvertent
activation. In addition, the needle retraction automatically clamps the
tubing, reducing the risk of exposure to blood.
The VanishPoint® BCS features automated, in-vein activation,
which virtually eliminates exposure to the contaminated needle,
effectively reducing the risk of needlestick injuries and preventing
reuse. The wingless design allows for easy disposal. The VanishPoint®
BCS contains no natural rubber latex, no DEHP, and no PVC. The
kink-resistant tubing is available in 7" and 12" lengths. This new
product is available in a variety of needle gauges. The trigger
indicator is color coded to indicate needle gauge. The clear body of the
device allows for flashback visualization.
Studies have shown that superior needlestick prevention is achieved by
safety devices with automated safety features, as opposed to devices
with manually activated safety features. All VanishPoint®
safety devices feature in-patient, automated safety designs to minimize
exposure to contaminated needles and reduce the risk of needlestick
Retractable Technologies, Inc.